Side-by-side comparison of AI visibility scores, market position, and capabilities
Oklahoma City multi-basin oil & gas E&P (NYSE: DVN) ~$14B revenue; Permian Delaware Basin + Williston Bakken (Grayson Mill $5B acquisition), fixed+variable dividend pioneer, $1B FCF improvement plan competing with ConocoPhillips.
Devon Energy Corporation is an Oklahoma City, Oklahoma-based oil and natural gas exploration and production company — publicly traded on the New York Stock Exchange (NYSE: DVN) as an S&P 500 Energy component — operating primarily in the Permian Basin (Delaware Basin, Texas and New Mexico), Anadarko Basin (Oklahoma), Eagle Ford (South Texas), Powder River Basin (Wyoming), and Williston Basin (North Dakota), with approximately 1,700 employees producing approximately 750,000-800,000 barrels of oil equivalent per day. Devon announced a comprehensive business optimization plan targeting $1 billion in annual pre-tax free cash flow improvements by year-end 2026, focusing on improving margins and capital efficiency across operations — including well productivity optimization, overhead cost reduction, and marketing contract improvements. Devon acquired Grayson Mill Energy (a Williston Basin Bakken shale operator) in 2024 for approximately $5 billion in cash and stock, adding high-quality Williston Basin production that complements Devon's existing Permian Basin core position. Devon pioneered the "fixed plus variable dividend" model in the E&P sector — paying a base quarterly dividend plus a variable dividend linked to free cash flow generation each quarter — a capital return structure that has since been adopted by numerous E&P companies as a shareholder-friendly alternative to buybacks-only programs.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.